M. Mandelboim, “Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)”, acbr, vol. 5, no. 5, pp. 794–802, Oct. 2021.